Weighted Average Number of Shares Outstanding, Basic of C4 Therapeutics, Inc. from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
C4 Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q2 2021 to Q3 2025.
  • C4 Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 72.6M shares, a 4.22% increase year-over-year.
  • C4 Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 69.4M shares, a 39.8% increase from 2023.
  • C4 Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 49.6M shares, a 1.59% increase from 2022.
  • C4 Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 48.9M shares, a 6.13% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

C4 Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 72.6M +2.94M +4.22% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 71M +2.2M +3.19% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 70.8M +2.4M +3.51% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q4 2024 69.4M +19.7M +39.8% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 69.6M +20.4M +41.5% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 68.8M +19.7M +40.2% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 68.4M +19.4M +39.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q4 2023 49.6M +779K +1.59% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 49.2M +290K +0.59% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 49.1M +240K +0.49% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 49M +297K +0.61% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 48.9M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 48.9M +431K +0.89% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 48.8M +4.97M +11.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 48.7M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 48.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 43.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04

C4 Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 69.4M +19.7M +39.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 49.6M +779K +1.59% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 48.9M +2.82M +6.13% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 46M Jan 1, 2021 Dec 31, 2021 10-K 2023-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.